VFI is a not-for-profit company based in Switzerland, dedicated to provide its adjuvants and vaccine formulation expertise technologies in open-access to all interested groups.

VFI has offices and stare-of-the art laboratories in both Epalinges, Vaud (Biopôle) and Plan-les-Ouates, Geneva (Centre des Technologies Nouvelles).

Adjuvants are key components of modern vaccines, because of their ability to modulate immune responses, enable dose-sparing and improve efficacy of vaccines.

However, suitable adjuvants and the associated expertise required to effectively use them are not always openly available to vaccine researchers and developers worldwide.

VFI provides vaccine researchers and developers a variety of adjuvant-related laboratory and training activities. This includes advise on how to correctly formulate and characterize the adjuvants and the resulting vaccine formulations.

VFI is also developing a unique portfolio of adjuvants suitable for vaccines against disease of Global Health, especially for the benefit of low-resource countries.